Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1450 of 1863 entries
View as:

Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00002890 Org: User:
Start: 10/31/96 End: 01/31/01 Due: 01/31/02

Overnight Fasting After Completion of Therapy: The OnFACT Study

Phase: N/A Priority: Normal
NCT ID: NCT03523377 Org: User:
Start: 04/27/18 End: 04/30/26 Due: 04/30/27

Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins

Phase: N/A Priority: Normal
NCT ID: NCT01189877 Org: User:
Start: 08/31/10 End: 10/31/12 Due: 10/31/13

Bleeding in Critically Ill Children With Underlying Oncologic Diagnoses

Phase: N/A Priority: Normal
NCT ID: NCT04170231 Org: User:
Start: 11/18/19 End: 10/18/23 Due: 10/18/24

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Phase: N/A Priority: Normal
NCT ID: NCT00003101 Org: User:
Start: 08/31/97 End: 01/31/02 Due: 01/31/03

Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006038 Org: User:
Start: 02/29/00 End: 02/28/03 Due: 02/28/04

Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01268579 Org: User:
Start: 12/28/10 End: 10/31/22 Due: 10/31/23

Psychosocial Support for Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00133965 Org: User:
Start: 05/31/05 End: 04/30/11 Due: 04/30/12

Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00199862 Org: User:
Start: 02/29/04 End: 06/30/27 Due: 06/30/28

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005805 Org: User:
Start: 12/31/99 End: - Due: -

Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)

Phase: N/A Priority: Normal
NCT ID: NCT00610129 Org: User:
Start: 01/31/08 End: 01/31/10 Due: 01/31/11

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00436709 Org: User:
Start: 07/31/06 End: - Due: -

Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract

Phase: N/A Priority: Normal
NCT ID: NCT00582647 Org: User:
Start: 03/31/00 End: 12/31/25 Due: 12/31/26

A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05574114 Org: User:
Start: 10/05/22 End: 10/31/25 Due: 10/31/26

Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers

Phase: N/A Priority: Normal
NCT ID: NCT02465723 Org: User:
Start: 06/30/15 End: - Due: -

Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling

Phase: N/A Priority: Normal
NCT ID: NCT02713334 Org: User:
Start: 02/25/16 End: 02/25/26 Due: 02/25/27

Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00588237 Org: User:
Start: 08/31/06 End: 11/30/14 Due: 11/30/15

Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01186367 Org: User:
Start: 11/11/10 End: 05/17/23 Due: 05/17/24

Pembrolizumab (immunotherapy Drug) in Combination with Guadecitabine and Mocetinostat (epigenetic Drugs) for Patients with Advanced Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT03220477 Org: User:
Start: 08/04/17 End: 07/31/25 Due: 07/31/26

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003819 Org: User:
Start: 06/30/98 End: 03/31/09 Due: 03/31/10

A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02756247 Org: User:
Start: 05/09/16 End: 10/06/22 Due: 10/06/23

MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study

Phase: N/A Priority: Normal
NCT ID: NCT02301767 Org: User:
Start: 11/30/14 End: 11/30/25 Due: 11/30/26

Game-Based Physical Activity in Childhood Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04266080 Org: User:
Start: 02/07/20 End: 02/28/26 Due: 02/28/27

A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02643498 Org: User:
Start: 12/31/15 End: 12/16/24 Due: 12/16/25

Understanding How Methadone Treatment During Surgery Affects Pain Levels and the Need for Pain Medications After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05417100 Org: User:
Start: 06/06/22 End: 06/30/26 Due: 06/30/27